• Skip to main content
  • Skip to primary sidebar

SpotGamma™

S&P 500 Stock Market Gamma Trading Levels Based on Options Open Interest

  • About
  • Pricing
  • Academy
  • Resources
    • Tool Demos
    • Case Studies
    • Blog
    • Support Center
    • Daily Report
    • Free Trading Tools
      • Opening Setup Free Report
      • Options Profit Calculator
      • SPX Gamma Exposure
      • Implied Earnings Moves
    • Free Training
    • Report Card
  • Login

Sep 25 2026

Salesforce: A $1 Million Insider Buy Near a Key Options Level

Salesforce director David Kirk bought 4,176 CRM shares on September 18 at an average $239.33, spending about $999,000 and increasing his direct holdings to 18,748 shares. That is a sizable increase of +29% to his stake. He also bought shares last December with another director also buying $500K of stock in March at favorable prices under $200/share.

An insider spending personal money is a constructive vote of confidence, but it does not establish a floor for the stock. The opportunity depends on whether Salesforce can turn strong demand for its AI products into faster growth across the whole business. (Source: SEC filing)

OpenInsider table of CRM insider purchases showing director David Kirk buying 4,176 shares at $239.33 on September 18, 2026 for about $999,000, above earlier open-market purchases by Salesforce directors dating back to June 2024.
OpenInsider’s log of CRM insider purchases, led by director David Kirk’s roughly $999,000 buy on September 18.

1. Options: Movement is priced in, direction is not

Implied volatility for the October 23 expiration is approximately 40%. The near-the-money $240 call and put together cost about $21.15, implying a roughly 8.8% move through the next month.

Earnings are not due until early December but often can move on peers in the software sector reporting their results.

SpotGamma’s synthetic OI model below shows CRM entrenched in positive gamma positioning. The $250 strike is a large total gamma level that may be why the stock has retraced from that zone the past several weeks. SpotGamma’s positioning shows $230 as an important near-term options level, while the large concentration of gamma at $250 may help explain why the stock has struggled to extend through that area. With CRM now trading between those two levels, $230 and $250 provide useful reference points for the next directional move.

SpotGamma chart of CRM total gamma by strike showing the largest gamma concentration at the $250 strike, a low volatility point at $235 and the last close at $237.49.
SpotGamma’s CRM total gamma by strike, with the largest gamma concentration at the $250 strike.

Options volatility skew is remaining calm despite the recent rally. The notable point is what the options market is not doing: despite the insider purchase, upside volatility has not become particularly expensive. Put skew remains modestly elevated and overall skew is subdued relative to its 90-day range. In other words, the insider is expressing conviction through stock while the options market has yet to price an unusually bullish outcome.

Looking at the SpotGamma vol skew chart below shows that implied volatility remains subdued. The IV skew is below 90 day averages as the teal line is below the average shaded area. The options market is simply assessing fair value to the stock at these levels while insiders are buying the stock.

2. Fundamentals: A solid business with an AI growth test

Salesforce generated $11.3 billion of fiscal second-quarter revenue, up 11% from a year earlier. Its current remaining performance obligation—contracted revenue expected over the next 12 months—rose 14% to $33.5 billion. Agentforce and Data 360 annual recurring revenue reached nearly $3.9 billion, up more than 210%. These numbers support the case that customers are buying into the AI platform.

The qualification matters: $456 million of quarterly revenue came from Informatica, and a little more than three percentage points of Salesforce’s projected 11%–12% full-year revenue growth comes from that acquisition. Management still expects only about 4%–5% full-year free cash flow growth. The bullish case improves if AI demand lifts organic sales, rather than simply adding fast-growing products within a slower-growing core. (Source: Salesforce Investor Relations)

3. Technicals: The buy is near a decision point

CRM daily candlestick chart from late 2025 through September 2026 with moving averages, anchored VWAP and volume profile, showing the rally off June lows to near $270 and a pullback toward $240 above the value area high near $230.
CRM daily chart: the 60%+ rally off the summer lows, followed by a pullback toward the $230 area.

The recent 60%+ rally has been impressive but perhaps even more intriguing is the insider buying adding stock after a sizable rally off lows.

The $230 area is the first level to watch after the September 22 low of $229.81. A sustained recovery above roughly $242–$245 would suggest buyers are regaining control. A break below $230 would weaken the near-term rebound case as the open gap below becomes a vacuum, regardless of the insider purchase. These are chart reference levels, not guarantees of support or resistance.

The takeaway: Kirk’s nearly $1 million purchase is notable because it came after CRM had already rallied sharply from its summer lows—not during the selloff. Meanwhile, SpotGamma positioning identifies $230 as an important near-term level, with substantial gamma concentrated around $250.

Fundamentally, the question is whether rapid Agentforce and Data 360 adoption can translate into faster organic growth across Salesforce’s much larger core business. Until that becomes clearer, the insider purchase is best viewed as evidence of long-term conviction rather than a signal that the recent correction is necessarily over.

That creates a fairly clean setup: $230 is the level to watch on the downside, $250 is the key options level above, and the insider has just put roughly $1 million of his own capital to work between them.

Open-market insider purchases are generally more useful as signals of longer-term conviction than as short-term timing indicators. Kirk’s purchase therefore shouldn’t be read as a prediction that CRM has made its low at $230.

Share This Article

  • Share
  • Twitter
  • LinkedIn
  • Reddit
  • Facebook

Written by SpotGamma · Categorized: Market Analysis

Don’t have an account with SpotGamma?

Choose the plan you want today to view unique support and resistance levels, access Founder’s Notes and expert commentary, daily trading ranges, and entrance into our private Discord.

 

 

 

Primary Sidebar

Related Resources

  • Salesforce: A $1 Million Insider Buy Near a Key Options Level

    Salesforce: A $1 Million Insider Buy Near a Key Options Level

    September 25, 2026
  • Erasca’s November Catalyst: Promising Data, High Expectations and Strategic Optionality

    Erasca’s November Catalyst: Promising Data, High Expectations and Strategic Optionality

    September 24, 2026
  • NDX Call Skew Has Room While S&P Vol Contracts: Kochuba on tastylive

    NDX Call Skew Has Room While S&P Vol Contracts: Kochuba on tastylive

    September 22, 2026
  • Costco Earnings: What Shoppers—and Options—Are Telling Us

    Costco Earnings: What Shoppers—and Options—Are Telling Us

    September 22, 2026
  • The S&P500’s Diversification Problem

    The S&P500’s Diversification Problem

    September 20, 2026
  • youtube
  • x
  • Privacy Policy
  • Disclaimer
  • Terms & Conditions
  • Support Center
  • Media
  • Contact Us

©2026 TenTen Capital LLC DBA SpotGamma

All SpotGamma materials, information, and presentations are for educational purposes only and should not be considered specific investment advice nor recommendations. Futures, foreign currency and options trading contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing one's financial security or lifestyle. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. Testimonials appearing on this website may not be representative of other clients or customers and is not a guarantee of future performance or success.

View Full Risk Disclosure